Current
25.7×
5-Year Average
31.0×
All-Time High
112.7×
All-Time Low
10.6×
P/E Ratio daily chart for Thermo Fisher Scientific (TMO)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for Thermo Fisher Scientific (TMO) from 2001 to 2025
| 2025 | $217.87B | $6.71B | 32.4× | +1.0× | |
| 2024 | $199.17B | $6.34B | 31.4× | -2.8× | |
| 2023 | $205.42B | $6.00B | 34.3× | +3.3× | |
| 2022 | $215.32B | $6.95B | 31.0× | -3.1× | |
| 2021 | $262.89B | $7.72B | 34.0× | +5.0× | |
| 2020 | $184.91B | $6.38B | 29.0× | -6.1× | |
| 2019 | $129.62B | $3.70B | 35.1× | +4.5× | |
| 2018 | $89.96B | $2.94B | 30.6× | -3.6× | |
| 2017 | $76.14B | $2.23B | 34.2× | +6.7× | |
| 2016 | $55.68B | $2.02B | 27.5× | -1.1× | |
| 2015 | $56.67B | $1.98B | 28.7× | +2.4× | |
| 2014 | $49.84B | $1.89B | 26.3× | -5.3× | |
| 2013 | $40.29B | $1.27B | 31.6× | +12.2× | |
| 2012 | $22.84B | $1.18B | 19.4× | +6.8× | |
| 2011 | $16.79B | $1.33B | 12.6× | -8.1× | |
| 2010 | $21.51B | $1.04B | 20.8× | -2.2× | |
| 2009 | $19.53B | $850.30M | 23.0× | +8.6× | |
| 2008 | $14.23B | $990.80M | 14.4× | -17.3× | |
| 2007 | $24.08B | $761.10M | 31.6× | -81.0× | |
| 2006 | $19.03B | $168.90M | 112.7× | +90.6× | |
| 2005 | $4.91B | $223.22M | 22.0× | +8.6× | |
| 2004 | $4.86B | $362.78M | 13.4× | -7.4× | |
| 2003 | $4.16B | $200.01M | 20.8× | +10.2× | |
| 2002 | $3.28B | $309.73M | 10.6× | — | |
| 2001 | $4.16B | −$781.00K | — | — |
- 202532.4×
- 202431.4×
- 202334.3×
- 202231.0×
- 202134.0×
- 202029.0×
- 201935.1×
- 201830.6×
- 201734.2×
- 201627.5×
- 201528.7×
- 201426.3×
- 201331.6×
- 201219.4×
- 201112.6×
- 201020.8×
- 200923.0×
- 200814.4×
- 200731.6×
- 2006112.7×
- 200522.0×
- 200413.4×
- 200320.8×
- 200210.6×
- 2001—
About P/E Ratio at Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific (TMO) P/E ratio is 25.7× as of June 5, 2026. The 5-year average is 31.0×. The sector median currently stands at 25.0×. The current ratio is at the 9th percentile of its own 10-year history.
Thermo Fisher Scientific (TMO) historical P/E ratio has ranged from a low of 10.6× (2002) to a high of 112.7× (2006) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Thermo Fisher Scientific P/E Ratio by Year
Thermo Fisher Scientific P/E Ratio 2025: 32.4×
Thermo Fisher Scientific (TMO) P/E ratio in 2025 was 32.4×, expanded from 31.4× the prior year.
Thermo Fisher Scientific P/E Ratio 2024: 31.4×
Thermo Fisher Scientific (TMO) P/E ratio in 2024 was 31.4×, contracted from 34.3× the prior year.
Thermo Fisher Scientific P/E Ratio 2023: 34.3×
Thermo Fisher Scientific (TMO) P/E ratio in 2023 was 34.3×, expanded from 31.0× the prior year.
Thermo Fisher Scientific P/E Ratio 2022: 31.0×
Thermo Fisher Scientific (TMO) P/E ratio in 2022 was 31.0×, contracted from 34.0× the prior year.
Thermo Fisher Scientific P/E Ratio 2021: 34.0×
Thermo Fisher Scientific (TMO) P/E ratio in 2021 was 34.0×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric